Human platelets express OATP 2 B 1 , an uptake transporter for atorvastatin

Department of Pharmacology, Research Center of Pharmacology and Experimental Therapeutics (J.N., G.J., M.G., S.B., S.O., K.S., W.S., D.R., H.K.K.), Department of Immunology and Transfusion Medicine (U.S., A.G.), Ernst-Moritz-Arndt-University, Greifswald, Germany and Department of Surgery, and The Eccles Institute of Human Genetics, University of Utah, Salt Lake City, UT 84112, USA (H.S.), Division of Membrane Transport and Drug Targeting, Graduate School of Pharmaceutical Sciences, Tohoku University, Aoba, Aramaki, Aoba-ku, Sendai 980-8578, Japan (S.O., H.K., J.K., T.T.) DMD Fast Forward. Published on February 23, 2009 as doi:10.1124/dmd.108.024570

[1]  A. Gotto,et al.  The evolving role of statins in the management of atherosclerosis. , 2000, Journal of the American College of Cardiology.

[2]  A. Szuba,et al.  Influence of dehydroepiandrosterone on platelet aggregation, superoxide dismutase activity and serum lipid peroxide concentrations in rabbits with induced hypercholesterolemia. , 2000, Medical science monitor : international medical journal of experimental and clinical research.

[3]  Tetsuya Terasaki,et al.  Quantitative Atlas of Membrane Transporter Proteins: Development and Application of a Highly Sensitive Simultaneous LC/MS/MS Method Combined with Novel In-silico Peptide Selection Criteria , 2008, Pharmaceutical Research.

[4]  M. Fromm,et al.  Pharmacogenomics of human OATP transporters , 2006, Naunyn-Schmiedeberg's Archives of Pharmacology.

[5]  N. Lameire,et al.  Pharmacokinetics of atorvastatin and its metabolites after single and multiple dosing in hypercholesterolaemic haemodialysis patients. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[6]  M. Becchi,et al.  Occurrence and biological effects of cholesteryl sulfate on blood platelets. , 1995, Biochimica et biophysica acta.

[7]  J. Aznar,et al.  Effect of atorvastatin upon platelet activation in hypercholesterolemia, evaluated by flow cytometry. , 2005, Thrombosis research.

[8]  U. Cogan,et al.  Lovastatin decreases plasma and platelet cholesterol levels and normalizes elevated platelet fluidity and aggregation in hypercholesterolemic patients. , 1994, Metabolism: clinical and experimental.

[9]  C. Iden,et al.  Homocysteine Induces 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase in Vascular Endothelial Cells: A Mechanism for Development of Atherosclerosis? , 2002, Circulation.

[10]  P. K. Smith,et al.  Measurement of protein using bicinchoninic acid. , 1985, Analytical biochemistry.

[11]  H. Kroemer,et al.  The nucleotide transporter MRP4 (ABCC4) is highly expressed in human platelets and present in dense granules, indicating a role in mediator storage. , 2004, Blood.

[12]  D. Keppler,et al.  A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane. , 2000, American journal of physiology. Gastrointestinal and liver physiology.

[13]  R. Tsien,et al.  A new generation of Ca2+ indicators with greatly improved fluorescence properties. , 1985, The Journal of biological chemistry.

[14]  Markus Grube,et al.  EXPRESSION, LOCALIZATION, AND FUNCTION OF THE CARNITINE TRANSPORTER OCTN2 (SLC22A5) IN HUMAN PLACENTA , 2005, Drug Metabolism and Disposition.

[15]  P. Meier,et al.  Functional Analysis of the Extracellular Cysteine Residues in the Human Organic Anion Transporting Polypeptide, OATP2B1 , 2006, Molecular Pharmacology.

[16]  D. Rosskopf,et al.  Signal transduction of somatostatin in human B lymphoblasts. , 2003, American journal of physiology. Cell physiology.

[17]  A. Sedman,et al.  Multiple‐dose pharmacokinetics, pharmacodynamics, and safety of atorvastatin, an inhibitor of HMG‐CoA reductase, in healthy subjects , 1996, Clinical pharmacology and therapeutics.

[18]  R. Kim,et al.  Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics. , 2006, Gastroenterology.

[19]  J. Farmer.  High-dose atorvastatin after stroke or transient ischemic attack. , 2007, Current atherosclerosis reports.

[20]  M. Endres,et al.  Effects of Statins on Endothelium and Signaling Mechanisms , 2004, Stroke.

[21]  B. Kinsella,et al.  Effect of the statin atorvastatin on intracellular signalling by the prostacyclin receptor in vitro and in vivo , 2004, British journal of pharmacology.

[22]  Thomas Rau,et al.  Atorvastatin desensitizes beta-adrenergic signaling in cardiac myocytes via reduced isoprenylation of G-protein gamma-subunits. , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  L. Lemberg,et al.  Statin pleiotropy: fact or fiction? , 2004, American journal of critical care : an official publication, American Association of Critical-Care Nurses.

[24]  曲东锋.  Stroke Prevention by Aggressive Reduction in Cholesterol Levels , 2004 .

[25]  J. Mehta,et al.  Anti-thrombotic Effects of Atorvastatin-An Effect Unrelated to Lipid Lowering , 2002, Journal of cardiovascular pharmacology and therapeutics.

[26]  J. Nezu,et al.  Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family. , 2000, Biochemical and biophysical research communications.

[27]  D. Dixon,et al.  Activated platelets mediate inflammatory signaling by regulated interleukin 1β synthesis , 2001, The Journal of cell biology.

[28]  K. Swoboda,et al.  Escaping the Nuclear Confines: Signal-Dependent Pre-mRNA Splicing in Anucleate Platelets , 2005, Cell.

[29]  H. Kroemer,et al.  Subfractionation and purification of intracellular granule-structures of human platelets: an improved method based on magnetic sorting. , 2007, Journal of immunological methods.

[30]  G. Davı̀,et al.  Inhibition of thromboxane biosynthesis and platelet function by simvastatin in type IIa hypercholesterolemia. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[31]  W. Vainchenker,et al.  Biosynthesis of major platelet proteins in human blood platelets. , 1987, European journal of biochemistry.

[32]  W. Southern.  Intensive lipid lowering with atorvastatin in coronary disease. , 2005, The New England journal of medicine.

[33]  Nigel Mackman,et al.  Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenecity of human platelets , 2006, The Journal of experimental medicine.

[34]  J. Pincus.  Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study) , 1998, The American journal of cardiology.